Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

269
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
269
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

233
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
233
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

671
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
671
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

419
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
419
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

524
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
524
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

1.0K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From implicit to explicit: an evidence-informed deliberative process for health benefits package revision using the WHO UHC Compendium in Kyrgyzstan.

BMJ global health·2026
Same author

Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Sports-based mental health promotion for adolescents in rural Nepal: A pilot cluster-randomised controlled trial.

PLOS global public health·2026
Same author

Application of machine-learning algorithms to identify the key determinants of risk for HIV, hepatitis C and hepatitis B in primary care settings.

BMC infectious diseases·2026
Same author

Capacity and service readiness of facilities for non-communicable diseases in Bangladesh: a health system perspective from two selected districts.

BMC health services research·2026
Same author

Long-Term Clinical Findings of Retained Intraocular Ink After Scleral Tattooing: Insights Into the Ocular Glymphatic System.

Journal of vitreoretinal diseases·2026

Related Experiment Video

Updated: Oct 19, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.3K

Optima TB: A tool to help optimally allocate tuberculosis spending.

Lara Goscé1, Gerard J Abou Jaoude1, David J Kedziora2

  • 1University College London, London, United Kingdom.

Plos Computational Biology
|September 27, 2021
PubMed
Summary

Optimizing tuberculosis (TB) spending in Belarus can significantly improve health outcomes. Reallocating funds from inpatient to outpatient care and mass screening to active case finding can reduce TB prevalence and mortality by up to 45% and 50% respectively.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.3K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.3K

Related Experiment Videos

Last Updated: Oct 19, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.3K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.3K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.3K

Area of Science:

  • Public Health
  • Health Economics
  • Epidemiology

Background:

  • Tuberculosis (TB) causes significant mortality, predominantly in low- and middle-income countries with limited health resources.
  • Effective priority setting is crucial for maximizing the impact of constrained health budgets in TB control.
  • The Optima TB tool was developed to enhance analytical capacity for evidence-based priority setting in TB health benefits package design.

Purpose of the Study:

  • To outline the Optima TB framework and demonstrate its application in Belarus, a country with a high TB burden.
  • To analyze TB spending optimization to improve health impact and progress towards national TB targets.
  • To assess the potential of the Optima TB tool in informing resource allocation decisions for TB control.

Main Methods:

  • Utilized Optima TB, a population-based disease transmission model with programmatic cost functions and an optimization algorithm.
  • Integrated demographic, epidemiological, programmatic, cost, and spending data for general and high-risk populations (e.g., people living with HIV).
  • Conducted an optimization analysis in Belarus, defining objectives and constraints in collaboration with local stakeholders, including experts and decision-makers.

Main Results:

  • Redistributing current TB spending in Belarus can improve health impact.
  • Shifting funding from inpatient to outpatient care models could reduce TB prevalence by up to 45% by 2035.
  • Transitioning from mass screening to active case finding strategies could reduce TB mortality by up to 50% and drug-resistant TB by 40% by 2035, without additional financial resources.

Conclusions:

  • The case study in Belarus demonstrates that reallocating TB spending can substantially improve TB outcomes.
  • The Optima TB tool and similar modeling approaches can effectively support evidence-based priority setting for TB control.
  • Optimized TB spending strategies can help achieve national TB targets efficiently, even with limited financial resources.